Novolog and Diabetic hyperglycaemic coma - a phase IV clinical study of FDA data

Summary:

Diabetic hyperglycaemic coma is reported as a side effect among people who take Novolog (insulin aspart recombinant), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lantus, and have Diabetes mellitus inadequate control.

The phase IV clinical study analyzes which people have Diabetic hyperglycaemic coma when taking Novolog. It is created by eHealthMe based on reports of 55,653 people who have side effects when taking Novolog from the FDA, and is updated regularly.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

What is Diabetic hyperglycaemic coma?

Diabetic hyperglycaemic coma (diabetic coma occurs when blood sugar gets too high and the body becomes severely dehydrated) is found to be associated with 27 drugs and 96 conditions by eHealthMe. Check the latest studies of Diabetic hyperglycaemic coma.

On Jul, 16, 2026

55,653 people reported to have side effects when taking Novolog.
Among them, 29 people (0.05%) have Diabetic hyperglycaemic coma.

Could Novolog cause Diabetic hyperglycaemic coma?

Among these 29 people:

How long have people been on Novolog when they have Diabetic hyperglycaemic coma? *

What is the gender of people who have Diabetic hyperglycaemic coma when taking Novolog? *

female: 55.17 %
male: 44.83 %

What is the age of people who have Diabetic hyperglycaemic coma when taking Novolog? *

What are other drugs people take besides Novolog? *

What are other side effects people have besides Diabetic hyperglycaemic coma? *

Blood Glucose Increased: 11 people, 37.93%
Drug Ineffective: 5 people, 17.24%
Hyperglycemia (high blood sugar): 3 people, 10.34%
Lower Limb Fracture: 3 people, 10.34%
Glycosylated Haemoglobin Increased: 3 people, 10.34%
Gait Disturbance: 3 people, 10.34%
Fall: 3 people, 10.34%
Hypoglycaemic Coma (coma due to deficiency of glucose in the bloodstream): 3 people, 10.34%
Blindness: 3 people, 10.34%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 6.90%

What are the existing conditions these people have? *

Mood Swings (an extreme or rapid change in mood): 2 people, 6.90%
Hypoglycemia (low blood sugar): 2 people, 6.90%
Diabetes Mellitus Inadequate Control: 2 people, 6.90%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.45%
High Blood Pressure: 1 person, 3.45%
Cyst (a closed sac): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and have Diabetic hyperglycaemic coma?

- Check whether Diabetic hyperglycaemic coma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolog:

Novolog (56,160 reports)

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetic hyperglycaemic coma:

Diabetic hyperglycaemic coma (27 drugs)

Browse all the conditions that are associated with Diabetic hyperglycaemic coma:

Diabetic hyperglycaemic coma (96 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novolog) and Novolog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.